Decreased total bleeding events with reduced doses of Enoxaparin versus unfractionated heparin in high risk unstable angina;Disminución de hemorragias totales con dosis reducidas de enoxaparina en angina inestable de alto riesgo. Estudio ENHNFAI. (ENoxaparina vs Heparina No Fraccionada en Angina Inestable). Informe preliminar

Archivos de Cardiologia de Mexico

Volumn 72, Issue 3, 2002, Pages 209-219

  Victoria Campos, José ^a   Juárez Herrera, Úrsulo ^a   Rosas Peralta, Martín ^a   Lupi Herrera, Eulo ^a   González Pacheco, Héctor ^a   Martínez Sánchez, Carlos ^a   Chuquiure Valenzuela, Eduardo ^a   Vieyra Herrera, Gerardo ^a   Cardozo Zepeda, Carlos ^a   Barrera Sánchez, Carlos ^a   Reyes Corona, Jesús ^a   Cortina de la Rosa, Evelyn ^a   De la Peña Díaz, Aurora ^a   Izaguirre Ávila, Raúl ^a   De la Peña Fernández, Andrés ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Enoxaparine; Total bleeding; Unstable angina

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; HEPARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTIBODY BLOOD LEVEL; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; RANDOMIZED CONTROLLED TRIAL; UNSTABLE ANGINA PECTORIS;

EID: 0036630070     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD: ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations. Circulation 2000; 102: 1193-1209.
2. Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aguirre FV: Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry. Am Heart J 1999; 138: 1065-1072.
3. Fox KA, Kokkinos DJ, Deckers J, Keil U, Maggioni A: The ENACT study: A pan-European survey of acute coronary syndromes. Eur Heart J 2000; 21: 1440-1449.
4. Fuster VBL, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-50, 310-18.
5. Théroux P, Ouiment H, McCans J: Aspirin, heparin or both to treat acute unstable angina. N Engl J Med 1988; 319: 1105-1111.
6. Braunwald E: Unstable angina: A classification. Circulation 1989; 80: 410-414.
7. Braunwald E, Jones RH, Mark DB: Diagnosing and managing unstable angina. Agency for health care policy and research. Circulation 1994; 90: 613-22.
8. Braunwald E, Califf RM, Cannon ChP, Fox KA, Fuster V, Gibler B, et al: Redefining medical treatment in the management of unstable angina. Am J Med 2000; 108: 41-53.
9. Antman EM, Fox KM: Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: Proposed revisions. Am Heart J 2000; 139: 461-475.
10. Maynard SJ, Scott GO, Riddell JW, Adgey AJ: Management of acute coronary syndromes. Br Med J 2000; 321: 220-223.
11. Elliot EM: Cardiac specific troponina I levels to predict the risk of mortality in the patients with acute coronary syndromes. N Engl J Med 1996; 18: 1342-49.
12. Fragmin and fast revascularization during instability in coronary artery disease investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicentre study. Lancet 1999; 354: 708-15.
13. Oler A, Whooley MA, Oler J, Grady D: Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA 1996; 276: 811-15.
14. Hirsh J, Bates SM: The emerging role of low molecular-weight heparin in cardiovascular medicine. Progr Cardiovasc Dis 2000; 42: 235-46.
15. Kaul S, Shah PK: Low molecular weight heparin in acute coronary syndrome: Evidence for superior or equivalent efficacy compared with unfractionated heparin review article. J Am Coll Cardiol 2000; 35: 1699-712.
16. Armstrong PW: Heparin in acute coronary disease - Requiem for a heavy weight. N Engl J Med 1997; 337: 492-94.
17. The thrombolysis in myocardial infarction (TIMI) 11 a trial investigators. Dose-ranging trial of enoxaparin for unstable angina: Results of TIMI 11A. J Am Coll Cardiol 1997; 29: 1474-82.
18. Cohen M, Demers Ch, Gurfinkel EP, Turpie AG: A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease. (ESSENCE). N Engl J Med 1997; 337: 447-52.
19. Antman EM, McCabe CH, Gurfinkel EP: Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 11B Trial. Circulation 1999; 100: 1593-601.
20. Fragmin and fast revascularization during instability in coronary artery disease investigators: Long-term low molecular mass heparin in unstable coronary-artery disease: FRISC II prospective randomized multicenter study. Lancet 1999; 354: 701-7.
21. Cannon CP, Weintraub WS, Demopoulos LA: Comparison of early invasive and conservative strategies implement with unestable coronary syndromes treated with glycoprotein IIb/IIIa inhibitor-Tirofiban. N Engl J Med 2001; 344: 187-197.